Browse > Article
http://dx.doi.org/10.3857/roj.2013.31.4.267

A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma  

Jo, Sunmi (Department of Radiation Oncology, Inje University Haeundae Paik Hospital)
Shim, Hye Kyung (Department of Nuclear Medicine, Inje University Haeundae Paik Hospital)
Publication Information
Radiation Oncology Journal / v.31, no.4, 2013 , pp. 267-272 More about this Journal
Abstract
Although significant advances in the treatment of intrahepatic lesions, it is reported that the prognosis for patients with hepatocellular carcinoma (HCC) who have extrahepatic metastasis remains poor. We report a patient with lung, liver, brain, bone and subcutaneous metastasis from HCC who has survived more than 7 years maintaining relatively good performance status as a result of repeated therapies. A 55-year-old male patient with HCC underwent right lobectomy of the liver and cholecystectomy in September 2006. He received wedge resection for lung metastasis twice (July 2009, January 2011) and Gamma Knife stereotactic radiosurgery for brain metastasis (April 2011). Over the last 3 years, he has developed metastasis in subcutaneous tissues, muscle, and bone with pain. He has undergone 7 courses of radiotherapies for subcutaneous tissues, muscle, and bone metastasis and been prescribed sorafenib and he is still capable of all self-care.
Keywords
Hepatocellular carcinoma; Neoplasm metastasis; Radiotherapy;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Huang YJ, Tung WC, Hsu HC, Wang CY, Huang EY, Fang FM. Radiation therapy to non-iatrogenic subcutaneous metastasis in hepatocellular carcinoma: results of a case series. Br J Radiol 2008;81:143-50.   DOI   ScienceOn
2 Jung SM, Jang JW, You CR, et al. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol 2012;27:684-9.   DOI   ScienceOn
3 Seong J, Koom WS, Park HC. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int 2005;25: 261-5.   DOI   ScienceOn
4 Niibe Y, Kenjo M, Kazumoto T, et al. Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma : 84 subjects of a population of more than 5,000. Int J Radiat Oncol Biol Phys 2006;66:1366-9.   DOI   ScienceOn
5 Niibe Y, Kuranami M, Matsunaga K, et al. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Anticancer Res 2008; 28(6B):3929-31.
6 Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-405.   DOI   ScienceOn
7 Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 2010;40:107-11.   DOI   ScienceOn
8 Koukourakis MI, Papadopoulou A, Kyrgias G. Long-term survival of a patient with multiple abdominal metastasis from endometrial carcinoma treated with multi-portal conformal re-irradiation and chemotherapy. Hematol Oncol Stem Cell Ther 2011;4:45-7.   DOI   ScienceOn
9 Yun HG. A case report of a gastric cancer patient with a good quality of life after radiotherapies to 17 metastases for 4 years. J Korean Soc Ther Radiol Oncol 2011;29:127-33.   DOI   ScienceOn
10 Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14.   DOI   ScienceOn
11 Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011;117:4475-83.   DOI   ScienceOn
12 Taura N, Hamasaki K, Nakao K, et al. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:1177-83.   DOI   ScienceOn
13 Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.   DOI   ScienceOn
14 Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J GastroenteroI 2007;13:414-20.   DOI
15 Natsuizaka M, Omura T, Akaike T. et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781-7.   DOI   ScienceOn
16 Zachau L, Zeckey C, Schlue J, et al. Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood. World J Surg OncoI2012;10:98.   DOI
17 Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.   DOI   ScienceOn
18 Kim HY, Park JW, Nam BH, et al. Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatme nts. J Gastroenterol Hepatol 2011;26:1612-8.   DOI   ScienceOn